K&L Gates acted as lead Australian lawyers in Mesoblast Limited’s A$170 million raising, one of the largest international private equity financings for a biotech company in recent years. The world’s largest regenerative medicine company, Mesoblast raised the funds through a targeted institutional private placement, with the issue structured to comply with U.S. SEC exemptions (144a and Regulation S) as well as applicable UK and local Asian security laws.
Tags: K&L Gates LLPDonovan Hatem LLP – Timothy P. Frawley has Joined the Firm as a Partner
Timothy P. Frawley joined the firm as a Partner in the Professional Practices and Insurance & Tort Litigation Groups.
Tags: Donovan Hatem LLPG. Daniel McCarthy Joins Gibbons as a Director in the Corporate Department
Gibbons P.C. is pleased to announce that G. Daniel McCarthy, has joined the firm as a Director in the Corporate Department.
Tags: Gibbons P.C.Davis Polk – Tempur-Pedic $1.77 Billion Acquisition Financing
Davis Polk advised Merrill Lynch, Pierce, Fenner & Smith Incorporated as sole lead arranger and bookrunner in connection with $1.77 billion of financing provided to Tempur-Pedic International Inc. for its acquisition of Sealy Corporation, which closed on March 18, 2013. The financing consists of $1.07 billion in senior secured term loan facilities, a $350 million senior secured revolving credit facility and a $350 million senior unsecured bridge facility.
Tags: Davis Polk & Wardwell LLP | New YorkDavis Polk Advises Crestview Partners on Its Sale of Shares in Charter Communications
Davis Polk is advising Crestview Partners as member of an investor group in connection with the $2.617 billion sale of approximately 26.9 million shares and approximately 1.1 million warrants in Charter Communications, Inc. to Liberty Media Corporation. The investor group includes investment funds managed by, or affiliated with, Apollo Management, Oaktree Capital Management and Crestview Partners. The transaction is subject to the satisfaction of customary closing conditions and is expected to close in the first half of the second quarter of 2013.
Tags: Davis Polk & Wardwell LLP | New YorkDavis Polk Advises E*TRADE on Common Stock Offering
Davis Polk advised E*TRADE Financial Corporation in connection with an SEC-registered block trade by Citadel Equity Fund Ltd., an affiliate of Citadel LLC, of 27,394,448 shares of E*TRADE common stock. Citadel received aggregate proceeds of approximately $309 million from the offering. Citigroup was the sole underwriter.
Tags: Davis Polk & Wardwell LLP | Silicon ValleyVLP Strengthens Trademark Practice with Addition of Scott Austin
VLP Law Group LLP is very pleased to announce that trademark attorney Scott R. Austin, Board Certified by the Florida Bar in Intellectual Property Law, has joined the firm from Gordon & Rees LLP.
Tags: Silicon ValleyPillsbury Advises Deutsche Bank in the Sale of Its Muni Bond Trustee Unit to U.S. Bancorp
Pillsbury represented Deutsche Bank in U.S. Bancorp’s agreement to buy Deutsche Bank AG’s municipal bond trustee business. US Bancorp is the nation’s largest regional bank. The deal, expected to be completed in the third quarter, will add about $57 billion to the $3 trillion in assets under administration by U.S. Bancorp’s corporate-trust division. The transaction will build on US Bancorp’s trust business in California, Mississippi, New York, Tennessee and Texas.
Tags: Pillsbury Winthrop Shaw Pittman LLP | New YorkStibbe Advises Ziggo on a New EUR 800 Million Financing
Jones Day Welcomes Two Atlanta Health Care Investigations and Litigation Partners
The global law firm Jones Day has announced that Rebekah N. Plowman and Kristen Pollock McDonald have joined the Atlanta Office as partners in the Health Care Practice, where they will represent health care providers and life sciences companies in fraud and abuse investigations and litigation and regulatory compliance matters. Both were formerly partners in the Atlanta office of Nelson Mullins Riley & Scarborough LLP, where Ms. Plowman chaired the national Fraud and Abuse Practice.
Tags: Jones Day






